Oman International Hospital in Muscat, Oman

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

The Idealmed Global Healthcare Services (Idealmed GHS),  part of the european  health group IGHS, based in Coimbra, Portugal, starts the comissioning of the impressive “Oman International Hospital”.

Having participated in projects in Asia, Europe, Africa and in the Midle East, the extraordinary recently launched “Oman International Hospital” (OIH), is the perfect example of the Idealmed GHS capabilities. The OIH was fully conceived, designed and equipped by Idealmed GHS, that will now operate the Hospital in accordance with the most exigent international standards of quality.

With matchless conditions, the “Oman International Hospital” is already considered a landmark in Oman and assumes the ambition to lead the private health sector in the country and in the region, by providing the most advanced diagnostic and treatment solutions to all its users.

As per vision of the Idealmed GHS, the OIH also hosts a “Med Academy”, fully sustained by Siemens, that will ensure the continous training of all its Human Resources and the implementation of international programmes that promotes the sharing of competences and experiences.

Idealmed GHS integrates the international know-how of the most distinguished organizations, from Universities to R&D Institutions, leading multinacional companies, and other renowned hospital groups worldwide, with the single aim to conceive, develop and operate unique health projects, allowing its partners to have a single entity fully responsible for its implementation and governance.

Idealmed GHS assumes its international linkage with companies like Siemens, IBM, among many others, and the relation with the Academic world, in particular with the University of Coimbra, one of the oldest and most prestigious International Universities, as its key pillars of success.

“Knowing that in a modern world knowledge has no boundaries, at Idealmed GHS we merge the experience of all our partners, crafting healthcare projects and tailoring services to each individual.

“In all our facilities, we integrate culture with science, safety with confort, and aesthetics with functionality. Using the most innovative layouts and engeneering concepts and leading-edge eqquipment solutions, we combine techonlogical sophostication with the know-how of the most skilled and trained Human Resources.

“At Idealmed GHS we assume a disruptive vision for hospitals, leading innovative projects and  maximizing their sustainability and profitability, enhancing the confort and well-being of its users and surpassing their superlative expectations,” stated Dr. José Alexandre Cunha, Chairman Of Idealmed GHS.

“Crafting healthcare projects, tailoring services to each individual.”

“Toghether we do it better.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles